Share
Managing symptoms and finding the right support
Cancer treatment can bring on menopause earlier than expected or cause menopause-like symptoms. Hot flushes, broken sleep, vaginal dryness and changes in mood can affect everyday life. You do not have to wait until cancer treatment ends to ask for help. The best approach depends on your symptoms, the cancer you have had and your current medicines.
Some people find the sudden change particularly difficult. You may be recovering from treatment while also dealing with symptoms that friends your age have not experienced. Tell your team what is troubling you most, rather than feeling that these concerns are too small to mention.
Why can cancer treatment cause these changes?
The ovaries make hormones, including oestrogen, and release eggs. Removing both ovaries before natural menopause causes these hormones to fall suddenly. Chemotherapy or radiotherapy involving the ovaries can also reduce their function. Some hormone treatments deliberately lower oestrogen or temporarily switch off the ovaries. This can cause menopause-like symptoms without necessarily causing permanent menopause.
After chemotherapy, periods may stop temporarily or permanently. Whether ovarian function returns depends on factors including age and treatment. A single missed period, or the absence of hot flushes, cannot settle the question. Ask your team whether hormone tests would be useful and how treatment affects their interpretation.
A hysterectomy is an operation to remove the womb. If your ovaries were left in place, you will no longer have periods, but the ovaries may still produce hormones. Tell the team which organs were removed when discussing menopause symptoms.
What should you tell the team?
Describe the effect on your day, rather than trying to decide whether every symptom is definitely menopause. Useful examples include waking several times with sweats, struggling to work after a poor night, pain with sex or urinary discomfort.
For a few days, note the main symptom, roughly when it happens and what makes it harder to manage. You do not need an elaborate diary. Bring your cancer medicines and any products you have bought for menopause. Ask which problem to tackle first and when the plan should be reviewed.
Fatigue, poor concentration or a racing heart can have causes other than menopause. During chemotherapy, do not dismiss a fever as a hot flush. A temperature of 38°C (100.4°F) or above needs immediate contact with your cancer team; follow a lower threshold if your unit has given one.
Seek help if you feel suddenly very unwell even without a fever.
Making hot flushes and night sweats easier to manage
Light layers, a cooler room and bedding that is easy to change may make episodes more comfortable. Carry water if useful. Notice whether a particular drink, hot room or stressful situation repeatedly makes symptoms worse, without imposing a long list of unnecessary food restrictions. These are comfort measures, not guaranteed treatments.
At work, a fan, access to drinking water or permission to change clothing may help. At home, explain what is happening so that a partner can help with bedding or room temperature. A practical request is often easier to act on than simply saying you feel uncomfortable.
Cognitive behavioural therapy, or CBT, is a structured talking treatment that can help reduce how disruptive hot flushes and night sweats feel. A trial in women after breast cancer treatment found benefit. This does not mean symptoms are imagined: treatment helps with responses, coping and sleep. Ask whether an appropriately trained clinician or programme is available.
Are there medicines that do not contain hormones?
Yes. Depending on the situation, clinicians may consider certain antidepressant medicines, gabapentin or other non-hormonal treatments. A medicine used for hot flushes is not necessarily being prescribed because you have depression. The expected benefit, possible side effects and interactions all need checking.
For example, some antidepressants can interfere with the way tamoxifen is processed. Tell the prescriber if you take tamoxifen, and do not start or stop an antidepressant yourself. Some symptom treatments cause sleepiness, dizziness, constipation or dry mouth, which may already be problems during cancer treatment.
Ask: “Which option fits my cancer medicines, and what improvement would make it worth continuing?” Agree when to reassess. Newer menopause medicines are not automatically suitable for every cancer survivor; local availability, the current prescribing information and required monitoring matter.
Can I use hormone replacement therapy?
Hormone replacement therapy, or HRT, can help menopausal symptoms. Systemic HRT, such as tablets, patches or gels, acts throughout the body. After breast cancer it is generally not recommended, particularly when the cancer is sensitive to hormones, because some trials have found a higher risk of the cancer returning. The evidence is not the same for every type of HRT or every person.
Why is the evidence debated?
In the HABITS trial, women given HRT had more new breast-cancer events, including cancer returning or developing in the other breast. A 2022 analysis combining four randomised trials also found increased recurrence overall, particularly after hormone-sensitive breast cancer.
Not every study reached the same conclusion. The Stockholm trial did not find a clear increase in breast-cancer events overall, but it did find more cancers in the other breast. Both trials ended early, which limits what they can tell us.
A 2024 review found less conclusive results and suggested HRT might be considered in selected patients, particularly after cancers that were not sensitive to hormones. However, the results were uncertain enough that a meaningful increase in risk could not be ruled out. Recent reviews and a 2026 expert consensus also support more individual discussion when symptoms are severe. These are reviews of existing evidence, not new trials proving that HRT is safe. Differences in the hormones used, the people studied and the study methods help explain the disagreement.
If symptoms remain severe despite treatments that do not contain hormones, ask for joint advice from your oncologist and a clinician experienced in menopause. They can discuss your cancer's hormone sensitivity, your usual risk of recurrence, current cancer treatment, symptom burden and preferences. For some people, specialist discussion may include systemic HRT, with a clear understanding of the possible risks and remaining uncertainty.
After other cancers, the decision depends on the cancer type, your symptoms and health, including blood-clot risk. Ask for advice tailored to your diagnosis. A friend's prescription, or advice intended for people without a history of cancer, may not apply to you.
Do not stop an effective cancer hormone treatment because its side effects have become difficult: tell the team so they can discuss symptom treatment and, when appropriate, cancer-treatment options.
Vaginal dryness and urinary discomfort
Dryness can cause soreness during ordinary activities as well as pain with sex. A non-hormonal vaginal moisturiser used regularly and a suitable lubricant during sexual activity can help. Avoid perfumed products or washes that irritate the area. Pain, bleeding, discharge or burning when passing urine should be assessed rather than assumed to be dryness.
Low-dose vaginal oestrogen mainly treats the vagina and nearby tissues. It is different from systemic HRT and may sometimes be considered after breast cancer when non-hormonal options have not helped. Long-term breast-cancer safety is not completely certain.
The decision needs particular care if you take an aromatase inhibitor, a medicine that lowers oestrogen. Discuss the benefits and risks with your oncologist and gynaecologist.
The sexual-health article discusses comfort and intimacy in more detail. You can ask about these symptoms privately; you do not need a partner to seek help.
Protect sleep, mood and longer-term health
Treating night sweats may improve sleep, but persistent insomnia can need its own treatment. Try to keep a reasonably regular waking time and discuss pain, urinary symptoms or medicines that disturb sleep. Avoid changing prescribed steroid or cancer-medicine schedules yourself.
Early loss of ovarian hormones also makes bone health important. Ask whether you need a bone-density assessment, especially if other treatments increase bone loss. Suitable weight-bearing activity, resistance exercise and adequate nutrition can form part of the plan.
Calcium, vitamin D and bone medicines should be based on your intake, results and risk, not taken in large doses without advice.
Ask about routine checks for blood pressure, cholesterol and other factors affecting heart health. If anxiety, low mood or grief about fertility is affecting daily life, counselling or psychological support may help. Agree a manageable plan and a date to review it.
Common questions
If my periods have stopped, can I stop contraception?
No. Periods stopping during treatment does not always mean pregnancy is impossible. Continue the method and duration agreed with your team. HRT itself is not contraception. The fertility and contraception article explains this distinction.
Are herbal or natural menopause products safer?
Not necessarily. Evidence of benefit is inconsistent, and products may have hormone-like effects or interact with cancer medicines. Bring the actual ingredient list to your pharmacist before using them.
What is a useful first request?
“My symptoms are affecting sleep and daily life. Could we agree a menopause plan that is suitable for my cancer treatment?” Choose your two main concerns, discuss the options and leave with a review date.
Sources and further reading
- Macmillan Cancer Support. Menopause and cancer. Professionally reviewed patient guidance. Read source
- Servayge J, et al. Clinical guidelines for managing menopausal symptoms in women with (a history of) breast cancer. Facts, Views & Vision in ObGyn. 2023;15(4):297–308. Read source
- Macmillan Cancer Support. Hot flushes and sweating. Patient guidance. Read source
- Mann E, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncology. 2012;13(3):309–318. Read source
- The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023. Read source
- American College of Obstetricians and Gynecologists. Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer: Clinical Consensus. Obstetrics & Gynecology. 2021;138(6):950–960. Read source
- National Cancer Institute. Infection and Neutropenia during Cancer Treatment. Read source
- Glynne S, et al. Menopausal hormone therapy for breast cancer patients: what is the current evidence? Menopause. 2026;33(1):88–117. Evidence review and consensus. Read source
- Pandya KJ, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9488):818–824. Read source
- National Cancer Institute. Hot Flashes and Night Sweats (PDQ®), Health Professional Version. Evidence on non-hormonal treatments, including gabapentin. Read source
- Holmberg L, et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors (HABITS). Journal of the National Cancer Institute. 2008;100(7):475–482. Read source
- Fahlén M, et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. European Journal of Cancer. 2013;49(1):52–59. Read source
- Poggio F, et al. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 2022;191(2):269–275. Read source
- Coronado PJ, et al. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis. Menopause. 2024;31(3):234–242. Read source
- Granat LM, Pederson HJ, Kruse M. Menopausal hormone therapy in breast cancer survivors: A review. Maturitas. 2026;208:108929. Read source
Medically reviewed and approved by Dr (Prof) Vijay Agarwal
Professor and Lead Consultant – Medical Oncology
